Last updated on August 2018

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Brief description of study

This study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).

Clinical Study Identifier: NCT03002077

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Registry Team

Adams Clinical Trials
Watertown, MA United States
  Connect »

Clinical Trials Registry Team

Boston Clinical Trials
Boston, MA United States
  Connect »